Envision Healthcare (EVHC) Overweight Maintained, PT Raised to $54 at KeyBanc

KeyBanc affirmed its Overweight rating on Envision Healthcare (NYSE: EVHC) and raised its price target to $54.00 (from $46.00). Analyst Jason Gurda made note of a number of positives, including its strong growth outlook.

"We are reiterating our OW rating on EVHC and raising our PT to $54, based on our view that: 1) the Company is uniquely positioned via its three businesses to compete in an increasingly integrated care environment; 2) EVHC could see out-sized benefit from near-term M&A as its largest competitor is likely sidelined; and 3) we believe there is some modest upside opportunity to our high-10s/ low-20s EBITDA growth estimates for the next couple of years from further M&A, bundling and new service offerings," said Gurda.

For an analyst ratings summary and ratings history on Envision Healthcare click here. For more ratings news on Envision Healthcare click here.

Shares of Envision Healthcare closed at $44.40 yesterday.

You May Also Be Interested In

• Amazon.com (AMZN) PT Raised to $215 at UBS
• Comcast Corp (CMCSA) PT Lowered to $48 at Pivotal Research
• Jefferies Upgrades Husqvarna AB (HUSQB:SS) to Buy